“Even if you’re HIV-positive there’s life after if you take your medication”: experiences of people on long-term ART in South Africa: a short report

References

• Bassett, I. V., Coleman, S. M., Giddy, J., Bogart, L. M., Chaisson, C. E., Ross, D., … Losina, E. (2017). Barriers to care and 1-year mortality among newly diagnosed HIV-infected people in Durban, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 74(4), 432–438. doi: 10.1097/qai.0000000000001277
   PubMed Web of Science ®Google Scholar
• Bendassolli, P. F. (2013). Theory building in qualitative research: Reconsidering the problem of induction. Paper presented at the Forum Qualitative Sozialforschung/Forum: Qualitative Social Research.
   Google Scholar
• Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., Peterson, G. M., Bimirew, M. A., & Kassie, D. M. (2014). Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: A qualitative study from Ethiopia. PLoS One, 9(5), e97353. doi: 10.1371/journal.pone.0097353
   PubMed Web of Science ®Google Scholar
• Dahab, M., Charalambous, S., Hamilton, R., Fielding, K., Kielmann, K., Churchyard, G. J., & Grant, A. D. (2008). “That is why I stopped the ART”: Patients’ & providers’ perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health, 8, 63. doi: 10.1186/1471-2458-8-63
   PubMed Web of Science ®Google Scholar
• De Wet, H., & Kagee, A. (2016). Perceived barriers and facilitators to HIV testing in South African communities. Journal of Health Psychology, 1359105316664140. doi: 10.1177/1359105316664140
   Web of Science ®Google Scholar
• Fatti, G., Mothibi, E., Shaikh, N., & Grimwood, A. (2016). Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa. AIDS Care, 28(11), 1365–1372. doi: 10.1080/09540121.2016.1191605
   PubMed Web of Science ®Google Scholar
• Fox, M. P., Maskew, M., MacPhail, A. P., Long, L., Brennan, A. T., Westreich, D., … Sanne, I. M. (2013). Cohort profile: The Themba Lethu clinical cohort, Johannesburg, South Africa. International Journal of Epidemiology, 42(2), 430–439. doi: 10.1093/ije/dys029
   PubMed Web of Science ®Google Scholar
• Govindasamy, D., Ford, N., & Kranzer, K. (2012). Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: A systematic review. Aids (london, England), 26(16), 2059–2067. doi: 10.1097/QAD.0b013e3283578b9b
   PubMed Web of Science ®Google Scholar
• Grimsrud, A., Kaplan, R., Bekker, L. G., & Myer, L. (2014). Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme. Tropical Medicine & International Health, 19(9), 1029–1039. doi: 10.1111/tmi.12346
   PubMed Web of Science ®Google Scholar
• Krummenacher, I., Spencer, B., Du Pasquier, S., Bugnon, O., Cavassini, M., & Schneider, M. P. (2014). Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme. International Journal of Clinical Pharmacy, 36(4), 716–724. doi: 10.1007/s11096-014-9930-0
   PubMed Web of Science ®Google Scholar
• Motsoaledi, A. (2014). Health budget vote speech by the minister of health. Pretoria, South Africa: National Department of Health. Retrieved from http://www.health-e.org.za/wp-content/uploads/2014/07/Minister-of-Health-Budget-Vote-Speech-2014-15-.pdf
   Google Scholar
• National Department of Health South Africa. (2004). National antiretroviral treatment guidelines.
   Google Scholar
• Shisana, O., Rehle, T., Simbayi, L. C., Zuma, K., Jooste, S., Zungu, N., … Onoya, D. (2014). South African National HIV prevalence, incidence and behaviour survey, 2012. Retrieved from Cape Town.
   Google Scholar
• Treffry-Goatley, A., Lessells, R., Sykes, P., Barnighausen, T., de Oliveira, T., Moletsane, R., & Seeley, J. (2016). Understanding specific contexts of antiretroviral therapy adherence in rural South Africa: A thematic analysis of digital stories from a community with high HIV prevalence. PLoS One, 11(2), e0148801. doi: 10.1371/journal.pone.0148801
   PubMed Web of Science ®Google Scholar
• Tsondai, P. R., Wilkinson, L. S., Grimsrud, A., Mdlalo, P. T., Ullauri, A., & Boulle, A. (2017). High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa. Journal of the International AIDS Society, 20(Suppl 4), 21649. doi: 10.7448/ias.20.5.21649
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2014). 90-90-90 An abitious treatment target to help end the AIDS epidemic. Retrieved from http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf
   Google Scholar
• UNAIDS. (2015). HIV and AIDS estimates (2015). Retrieved from http://www.unaids.org/en/regionscountries/countries/southafrica
   Google Scholar
• van Loggerenberg, F., Gray, D., Gengiah, S., Kunene, P., Gengiah, T. N., Naidoo, K., & Grant, A. D. (2015). A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa. AIDS Patient Care and STDs, 29(5), 299–306. doi: 10.1089/apc.2014.0293
   PubMed Web of Science ®Google Scholar
• Wilkinson, L., Harley, B., Sharp, J., Solomon, S., Jacobs, S., Cragg, C., … Grimsrud, A. (2016). Expansion of the adherence club model for stable antiretroviral therapy patients in the Cape Metro, South Africa 2011–2015. Tropical Medicine & International Health, 21(6), 743–749. doi: 10.1111/tmi.12699
   PubMed Web of Science ®Google Scholar
• World Bank. (2017). Evaluation of the national adherence guidelines for chronic diseases in South Africa: The impact of differentiated care models on short-term indicators in HIV patients. Washington, DC: World Bank. Retrieved from https://openknowledge.worldbank.org/bitstream/handle/10986/29396/123683-WP-PUBIC-EvaluationofNationalAdherenceGuidelinesshorttermendpointsOct.pdf?sequence=6&isAllowed=y
   Google Scholar
• World Health Organisation. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infections. Retrieved from http://www.sahivsoc.org/Files/WHO20June202016.pdf
   Google Scholar
• Yehia, B. R., Stewart, L., Momplaisir, F., Mody, A., Holtzman, C. W., Jacobs, L. M., … Shea, J. A. (2015). Barriers and facilitators to patient retention in HIV care. BMC Infectious Diseases, 15, 246. doi: 10.1186/s12879-015-0990-0
   PubMed Web of Science ®Google Scholar